Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer
Status:
Completed
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of radiation therapy
combined with anti-PD-1 antibody SHR-1210 in patients with esophageal cancer